ISO 13019:2018

Tissue-engineered medical products — Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

Tissue-engineered medical products — Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

Digital Document2018 edition2018Purchase Options

Referenced standards

ASTM F2027-00ASTM F2150-07ASTM F2210-02ASTM F2212-02ASTM F2312-04ASTM F2315-03ASTM F2383-05ASTM F2451-05ISO 10993-1:2009ISO 12891-1:2015ISO 13022:2012ISO 14155-1:2003ISO 14155-2:2003ISO 14971:2007ISO 20391-1:2018ISO 9000:2015ISO/TS 10993-19:2006
Unit Price
USD76.44Save 22%
USD 98.00

PREVIEW

ISO 13019:2018

Tissue-engineered medical products — Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

Tissue-engineered medical products — Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

This document specifies test methods for the quantification of sulfated glycosaminoglycans (sGAG), one of the major extracellular matrix components in articular, meniscal, and elastic cartilages, and tissue-engineered cartilage constructs.

Edition2018
Published Date2018
Published ByInternational Standardization Organisation
Page Count17